{
  "ADD_TRANSACTION": "New Record",
  "SEQUENCE_NUM": "Sequence Number",
  "NEW":"NEW",
  "EXISTING":"EXISTING",
  "DATE_SUBMITTED": "Date Submitted (YYYY-MM-DD)",
  "SEQUENCE_DESCRIPT": "Regulatory Transaction Description",
  "IS_ACTCHANGES": "Same as Regulatory Activity Contact for this Submission?",
  "COMPANY_ID": "Company ID",
  "DOSSIER_ID": "Dossier ID",
  "DOSSIER_NAME": "Dossier Name",
  "IS_ECTD": "Is this an eCTD transaction?",
  "IS_SOLICITED": "Is this solicited information?",
  "SOLICITED_RQ": "Requester of Solicited Information",
  "SOLICITED_RQ_OTHER": "Other Requester Details",
  "REP_CONTACT_INFO": "Main Contact Information",
  "PROJ_MANAGER_NAME": "Name of Regulatory Project Manager, if known",
  "DATED": "Dated (YYYY-MM-DD)",
  "START_DATE": "Start Date (YYYY-MM-DD)",
  "END_DATE": "End Date (YYYY-MM-DD)",
  "REG_ACTIVITY": "Regulatory Activity",
  "REG_ACTIVITY_TYPE": "Regulatory Activity Type",
  "SEQUENCE_TYPE": "Regulatory Transaction Description",
  "VERSION_NO": "Version Number",
  "BRIEF_DESC": "Brief Description",
  "BRIEF_DESC_CHANGE": "Brief Description of change",
  "ADMINISTRATIVE": "Administrative",
  "BENEFIT_RISK_ASSESS": "Benefit Risk Assessment",
  "CANCEL_LETTER": "Cancellation Letter",
  "CHANGE_TO_DIN": "Change to DIN",
  "COMMENTS_NOC": "Comments on Notice of Decision",
  "COMMENTS_SUMMARY_BASIS": "Comments on Summary Basis of Decision (SBD)",
  "COMMENTS_REGULARTORY_DECISION": "Comments on Regulatory Decision Summary",
  "DIN_DISCONTINUED": "Notification of Discontinued Sale (DIN Cancellation)",
  "DRUG_NOTIF_FORM": "Drug Notification Form",
  "FOR_PERIOD": "For Period of",
  "INITIAL": "INITIAL",
  "MEETING_MINUTES": "Minutes of Meeting",
  "NOTIFICATION_CHANGE": "Notification of Change in Benefit-Risk Profile",
  "NOTIFICATION_INTERRUPT_SALE":"Notification Interruption of Sale",
  "PANDEMIC_APPL": "Pandemic Application",
  "POST_CLEARANCE_DATA": "Post Clearance Data",
  "POST_MARKET_SURV": "Post Marketing Surveillance",
  "POST_NOC_CHANGE": "Post NOC Change",
  "POST_AUTH_DIV1_CHANGE": "Post-Authorization Division 1 Change",
  "PRESUB_MEETING_PKG": "Submission Meeting Package",
  "PRESUB_MEETING_RQ": "Submission Meeting Request",
  "PRIORITY_REVIEW_RQ": "Priority Review Request",
  "PRISTINE_PM": "Pristine PM",
  "PRISTINE_PM_2LANG": "Second Language PM and Final Package Insert",
  "ADVISEMENT_LETTER_RESPONSE": "Response to Advisement Letter",
  "CLIN_CLARIF_RESPONSE": "Response to Clinical Clarification Request",
  "EMAIL_RQ_RESPONSE": "Response to e-mail Request ",
  "HSC_RQ_RESPONSE": "Response to Human Safety Clarification Request",
  "QHSC_RQ_RESPONSE": "Response to Quality & Human Safety Clarification Request",
  "CHSC_RQ_RESPONSE": "Response to Clinical & Human Safety Clarification Request",
  "QCHSC_RQ_RESPONSE": "Response to Quality, Clinical and Human Safety Clarification Request",
  "LABEL_CLARIF_RESPONSE": "Response to Labeling Clarification Request",
  "MHPD_RQ_RESPONSE": "Response to MHPD Request",
  "NOC_RESPONSE": "Response to NOC/c-QN",
  "NOD_RESPONSE": "Response to NOD",
  "NON_RESPONSE": "Response to NON",
  "NOL_RESPONSE": "Response to NOL",
  "PROCESSING_CLARIF_RESPONSE": "Response to Processing Clarification Request",
  "QUAL_CLIN_CLARIF_RESPONSE": "Response to Quality and Clinical Clarification Request",
  "QUAL_CLARIF_RESPONSE": "Response to Quality Clarification Request",
  "SCREENING_ACCEPT_RESPONSE": "Response to Screening Acceptance Letter",
  "SCREENING_CLARIF_RESPONSE": "Response to Screening Clarification Request",
  "SDN_RESPONSE": "Response to SDN",
  "PHONE_RQ_RESPONSE": "Response to Telephone Request",
  "RISK_COMMUN_DOC": "Risk Communication Document",
  "RMP_VERSION_DATE": "RMP",
  "SIGNAL_WORK_UP": "Signal Work Up",
  "UNSOLICITED_DATA": "Unsolicited Information",
  "YEAR_LIST_OF_CHANGE": "Year(s) of change, list of change number(s) ",
  "NONCLIN_CLARIF_RESPONSE": "Response to Non-clinical Clarification Request ",
  "BE_CLARIF_RESPONSE": "Response to BE Clarification Request",
  "RECON_DECIS_LTR_INTENT": "Reconsideration of Decision - Letter of Intent",
  "RECON_DECIS_RQ_RECON":  "Reconsideration of Decision - Request for Reconsideration",
  "RECON_DECIS_OTHER_INFO": "Reconsideration of Decision - Other Information",
  "LABEL_PREAPPROVAL_2LANG":"Second Language Label - Pre-Approval",
  "LIFECYCLE_TITLE": "Transaction Details",
  "REG_CONTACT_THIS": "Regulatory Activity Contact for THIS transaction",
  "REG_ACT_CONTACT": "Regulatory Activity Contact",
  "TRANSACTION_HDING": "Regulatory Information",
  "LOAD_TRANSACTION": "Load a Regulatory Transaction File",
  "COMPANY_INFO": "A. Company Information",
  "ADDRESS_INFO": "B. Address Information",
  "COMPANY_REP_THIS": "C. Company Representative",
  "GENERATE_FINAL": "Generate Final XML",
  "CONFIRM_CONTACT_VALID": "I confirm that the above regulatory activity contact information is valid.",
  "YEAR_CHANGE": "Year(s) of change, list of change number(s)",
  "YEARS": "Year",
  "REG_ACTIVITY_INSTRUCT":"Regulatory Activity Contact Instructions",
  "SAVE_INSTRUCT": "Transaction File Save Instructions",
  "CLARIF_RESPONSE":"Response to Clarification Request",
  "CORR_PATENT_MED":"Correspondence - Patented Medicines",
  "ALLEGATION_NOTICE":"Notice of Allegation",
  "FORM_IV":"Form IV",
  "FORM_V":"Form V",
  "CONSENT_LTR":"Consent Letter",
  "DATA_PROTECT_CORRESP":"Correspondence - Data Protection",
  "CHOOSE_REQUEST":"Choose a requester",
  "TRANSACT_INSTRUCT":"Regulatory Transaction Instructions",
  "LIST_DESCRIPT":"List Description",
  "SEQUENCE_CLEANUP":"eCTD Dossier Clean-up",
  "ADV_COMP_REQ": "Advertising Complaint Request for Information",
  "CSOtRMP": "Canadian Specific Opioid RMP",
  "DISSEM_LIST": "Dissemination List",
  "FOREIGN_SAFETY_NOTIFICATION": "Foreign Safety Action Notification",
  "ISSUE_SAFETY_REQUEST": "Issue Related Safety Request",
  "PATIENT_SAFETY_INFO": "Patient Safety Information (Medication error)",
  "PUB_RELEASE_INFO": "Public Release of Clinical Information",
  "RESSESS_ORDER": "Reassessment Order",
  "WRITTEN_CONSULT_REQ": "Request for Written Consultation",
  "TEST_STUDIES_ORDER": "Test and Studies Order",
  "TERM_COND_COMM": "Terms and Conditions Commitment",
  "YEAR": "Year",
  "CTN_ADMINISTRATIVE":"CTN-Administrative Change to",
  "CTN_APPENDIX":"CTN-Appendix",
  "CTN_CONTACT":"CTN-Contact change",
  "CTN_CROSS":"CTN-Cross Reference Letter",
  "CTN_DATA":"CTN-Data Safety Monitoring Committee",
  "CTN_DEAR":"CTN-Dear Investigator/Doctor Letter",
  "CTN_DILUENT":"CTN-Diluent Change",
  "CTN_DRUG_PROD":"CTN-Drug Product Change",
  "CTN_DRUG_SUBS":"CTN-Drug Substance change",
  "CTN_ENROLLMENT":"CTN-Enrollment Suspension",
  "CTN_ETHICS":"CTN-Ethics Board Communications",
  "CTN_EXCLUSION_INCLUSION":"CTN-Exclusion/Inclusion Criteria Revision",
  "CTN_INFORMED":"CTN-Informed Consent Form Update",
  "CTN_INVESTIGATOR":"CTN-Investigator’s Brochure Update",
  "CTN_NEW_MANUFACTURING":"CTN-New Manufacturing Site for",
  "CTN_NEW_PKG":"CTN-New Packaging/Labelling Site",
  "CTN_NEW_QC":"CTN-New QC Testing Site",
  "CTN_NOL":"CTN-NOL Response",
  "CTN_PACKAGING_LABELLING":"CTN-Packaging/Labelling Name Change",
  "CTN_PM":"CTN-PM Update",
  "CTN_PROTOCOL_INFO_UPDATE":"CTN-Protocol and Informed Consent Form Update",
  "CTN_PROTOCOL_UPDATE":"CTN-Protocol Update/Change",
  "CTN_QOS":"CTN-QOS Update",
  "CTN_REFUSALS":"CTN-Refusals by Foreign Regulatory Authorities/REBs",
  "CTN_REGULATORY":"CTN-Regulatory Hold",
  "CTN_RESPONSE":"CTN-Response to Information Request",
  "CTN_SAFETY":"CTN-Safety Update",
  "CTN_SHELF_PD":"CTN-Shelf Life Extension for DP",
  "CTN_SHELF_DS":"CTN-Shelf Life Extension for DS",
  "CTN_SITE":"CTN-Site Closure",
  "CTN_SOURCE":"CTN-Source Change of",
  "CTN_STRAIN":"CTN-Strain Change",
  "CTN_STUDY_COMPLETION":"CTN-Study Completion",
  "CTN_STUDY_DISC":"CTN-Study Discontinuation due to",
  "CTN_STUDY_EXT":"CTN-Study Recruitment Timeline Extension",
  "CTN_STUDY_SUS":"CTN-Study Suspension",
  "CTN_TRANS_OWN":"CTN-Transfer of Ownership",
  "CLINICAL":"CLINICAL",
  "CLINICAL_QUALITY":"CLINICAL & QUALITY",
  "QUALITY":"QUALITY",

  "REQUESTER_NAME":"Name of requester",
  "REQUESTER_NAME2":"Name of requester",
  "DEFER_FEES":" A deferral of payment is requested with this transaction.",
  "DEFER_STATEMENT":"The statement supporting the deferral request is included.",
  "FEE_REMISSION":"Fee Remission is requested with this transaction",
  "STATEMENT_REVENUE":"A statement signed by the individual responsible for the applicant's financial affairs is included to certify that the fee payable is greater than 10% of the anticipated gross revenue",
  "SUB_CLASS":"Submission Class",
  "FEE_AMOUNT":"Fees",
  "FEE_DESCRIPTION":"Submission Description",
  "REMISSION_ELIGIBLE":"You are eligible to apply for fee remission. The submission fee is greater than 10% of anticipated gross revenues.",
  "REMISSION_INELIGIBLE":"You are not eligible to apply for fee remission. The submission fee is less than 10% of anticipated gross revenues.",
  "IS_FEE_TRANSACTION":"Are new or revised fees associated with this transaction?",
  "REGULATORY_FEES":"Fees",
  "GROSS_REVENUE":"Anticipated gross revenue for this drug product during the fee verification period",
  "TEN_PERCENT_REVENUE": "10% of anticipated gross revenue",
  "REQUIRED_DOC":"Required Documentation",
  "SUPPORTING_DOC":"Please include the required signed statement AND at least one of the support documentation to establish that the applicable fee payable is greater than 10% of the anticipated gross revenue from sales of the drug product in Canada during the fee verification period.",
  "EST_MARKET_SHARE":"Estimated market share (that is [i.e.], product's market potential compared to the total market for similar products in Canada)",
  "SIMILAR_PRODUCT":"Comparison to similar products on the Canadian market or other similar markets (e.g., United States, European Union)",
  "SALES_HISTORY":"Sales history prior to product upgrades or sales history of similar products",
  "MARKETING_PLAN":"Marketing plan/product plan for the drug product",
  "AVG_SALES":"Average sale price and demand",
  "FEES_LESS10K":"Fees of $10,000 or less must be paid at the time of filing of the submission, supplement or application. Please complete the",
  "ADVANCE_PAYMENT":"Advance Payment Details for Drug Submissions and Master Files.",
  "SPONSOR_INVOICE":"Review fees must not be included with the submission, supplement or application. Sponsors will be invoiced for fees of more than $10,000.",
  "PAYMENT_METHODS":"Please select all the payment methods you intend to use",
  "ONE_PAYMENT_METHOD":"Please select all the payment methods you intend to use",
  "ONE_FEE_DOC":"At least one of the support documentation to establish that the applicable fee payable is greater than 10% of the anticipated gross revenue from sales of the drug product in Canada during the fee verification period",
  "DEFER_INSTRUCT":"Deferral of Payment Instructions",
  "REMISSION_INSTRUCT":"Fee Remission Instructions",
  "CLASS_INSTRUCT":"Submission Class Instructions",
  "PRODUCT_INSTRUCT":"Product Name Instructions",
  "LIFECYCLE_INSTRUCT":"Lifecycle Management Table Instructions",
  "SEQUENCE_INSTRUCT":"Sequence Number Instructions",
  "CONTROL_INSTRUCT":"Control Number Instructions",
  "COMPANY_INSTRUCT":"Company Name Instructions",
  "COMPANY_ID_INSTRUCT":"Company ID Instructions",
  "DOSSIER_ID_INSTRUCT":"Dossier ID Instructions",
  "ADMIN_COMP_INSTRUCT": "Administrative Submission or Component Instructions",
  "PLEASE_REMIT":"Please pay the remission processing fee of $590 using the Advance Payment Details for Drug Submissions and Master Files.",
  "APPLY_DEFER":"You are applying for a deferral. Please send no payment with this form.",
  "BANK_DRAFT":"International Bank Draft",
  "MONEY_ORDER":"Money Order",
  "CHEQUE":"Cheque",
  "PAYMENT":"Payment",
  "CREDIT":"MasterCard/Visa/American Express (AMEX)",
  "BANK_WIRE":"Wire (include bank confirmation)",
  "EXISTING_CREDIT":"Existing credit",
  "PREFEERED_OPTION":"Bill Payment Service Option (preferred method)",
  "REG_TRANSACT":"Regulatory Transaction",
  "LIFE_REC":"Transaction Details Record",
  "ONELIFEREC": "One transaction details record is required.",
  "SAVELIFEREC": "One transaction details record is required to save.",
  "LIFECYCLECTRL.LIFECYCLEDETAILSFORM":"with a Transaction Details Record",
  "IS_NEW_ACTIVITY":"Is this transaction for a new or existing regulatory activity?",
  "IS_SIGNED_3RD_PARTY": "Will the submission be signed / filed by a third party on behalf of the manufacturer / sponsor?",
  "AUT_LETTER_NOTE": "A letter of authorization signed by the manufacturer/sponsor company must be provided in section 1.2.1 of the regulatory transaction.",
  "IS_PRIORITY":"Was this regulatory activity approved for priority review?",
  "IS_NOC":"Was this regulatory activity approved for NOC/C review?",
  "IS_ADMIN_SUBMISSION": "Is this regulatory activity an Administrative Submission or does this regulatory activity contain an administrative component?",
  "ADMIN_DESCRIPT":"Administrative Submission or administrative component description",
  "ADMIN_SUB_TYPE":"Reason for Administrative Submission or administrative component",
  "ACTIVITY_LEAD": "Regulatory Activity Lead",
  "OTHER_DOC_DETAILS": "Other Documentation Details",
  "B14-20160301-09":	"Pharmaceutical",
  "B14-20160301-02":	"Biological",
  "B14-20160301-10":	"Post-Market Vigilance",
  "B14-20160301-06":	"Consumer Health Product",
  "B14-20160301-11":	"Veterinary",
  "B14-20160301-04":	"Clinical Trial - Biologics",
  "B14-20160301-05":	"Clinical Trial - Pharmaceutical",
  "RESET": "RESET",
  "RESET_INFO" : "To enable the 'generate final XML' button, select the 'RESET' button to clear transaction specific fields.",
  "FEE_REMIT_NO_PAYMENT" :"Please remit no payment with this transaction. Payment of the fees will be required upon issuance of an invoice",
  "MITIGATION_TYPE" : "The following mitigation measures are available (select one). Sponsors must certify that they meet the criteria as outlined in the Food and Drug Regulations.",
  "CERTIFY_ORGANIZATION" : "We certify that our organization, including its affiliates, has",
  "CERTIFY_ORGANIZATION_A" : "a) a total number of employees less than 100 people, or",
  "CERTIFY_ORGANIZATION_B" : "b) a total annual gross revenue between $30,000 and $5 million.",
  "SMALL_BUSINESS_FEE_APPLICATION":"We have completed the Small Business Fee Mitigation Application and attached it with our submission/application.",
  "FIRST_SUBMISSION" : "This is my first submission/application",
  "CERTIFY_GOVERMENT_ORGANIZATION" : "We certify that our organization is a branch or agency of the Government of Canada or of a province or territory",
  "CERTIFY_URGENT_HEALTH_NEED":"We certify that the drug in our submission/application is on the List of Drugs for an Urgent Public Health Need as per the Access to Drugs in Exceptional Circumstances Regulations AND",
  "DRUG_THE_SAME_INGREDIENT":"a) the drug has the same medicinal ingredient, strength and route of administration, and is in a comparable dosage form, as a drug that may be imported under subsection C.10.001(2) of those Regulations;",
  "NO_DRUG_IDENTIFICATION_NUMBER":"b) no drug identification number has been assigned under section C.01.014.2 of those Regulations for the drug or for another drug that has the same medicinal ingredient, strength and route of administration and is in a comparable dosage form; and",
  "NO_NOTICE_COMPLIANCE":"c) no notice of compliance has been issued under section C.08.004 of those Regulations in respect of the drug or another drug that has the same medicinal ingredient, strength and route of administration and is in a comparable dosage form.",
  "CERTIFY_FUNDED_HEALTH_INSTITUTION":"We certify that our institution is funded by the Government of Canada or the government of a province or territory and that it is",
  "CERTIFY_FUNDED_HEALTH_INSTITUTION_A":"a) licensed, approved or designated by a province in accordance with the laws of the province to provide care or treatment to persons or animals suffering from any form of disease or illness; or",
  "CERTIFY_FUNDED_HEALTH_INSTITUTION_B":"b) owned or operated by the Government of Canada or the government of a province and that provides health services.",
  "TYPE_MIN": "End Date should not be earlier than Start Date.",
  "PROD_PROTOCOL": "Protocol Number",
  "CTA_FROM": "From [time]",
  "CTA_TO": "To [time]"
}